Hlib Chabaniuk

Fulgent Genetics details new protocols for variant reclassification and segregation testing recommendations

Fulgent Genetics details new protocols for variant reclassification and segregation testing recommendations
Fulgent Genetics updates variant policy

Fulgent Genetics has introduced new guidance outlining how the company approaches genetic variant reclassification and when segregation testing is advisable.

This update is designed to support healthcare professionals and patients seeking clarity on uncertain genetic findings, known as variants of unknown significance. The company encourages individuals and clinicians to review its testing policies page for comprehensive information.

Fulgent Genetics has previously emphasized its commitment to collaborative care, aiming to serve as more than just a laboratory vendor. The company has promoted a partnership approach focused on patient needs, as detailed in its prior guidance on patient-focused service. This background informs the company’s latest update on genetic testing protocols.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.